Skip to content

Regular Exercise for Peripheral Arterial Ischaemia: a Randomised Intervention Trial

The effect of progressive resistance training on walking distance in peripheral arterial disease.

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12609000457246
Acronym
REPAIR IT
Enrollment
120
Registered
2009-06-15
Start date
2009-07-30
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

120 participants with stable moderate to severe claudication from PAD as defined by lower extremity ultrasound, will be randomised to 6 months of supervised high intensity PRT, low intensity PRT or control which includes advice to do aerobic exercise. Our primary outcomes include absolute and initial claudication distances and 6-minute walk distance. Our secondary outcomes include resting arterial calf blood flow, resting brachial, hallux, ankle and distal thigh pressures and post exercise ankle, brachial pressures, change in clinical symptoms in relation to location of disease, dynamic muscle strength, power and endurance, vastus lateralis muscle biopsy to determine calf muscle fiber area, intramuscular lipid content, mitochondrial function and local inflammatory factors, arterial stiffness, blood lipids, systemic inflammatory factors, oxygen consumption, functional performance, self-efficacy, depressive symptoms and quality of life. Key outcomes will be measured at baseline and after the 6 month intervention and will be analysed by “intention to treat” with missing 6-month data imputed via the expectation maximisation algorithm.

Interventions

Progressive resistance training (PRT) or weight lifting training is a common type of strength training for developing the strength and size of skeletal muscles. It uses the force of gravity or in our case compressed air resistance to oppose the force generated by muscle through concentric or eccentric contraction. Effectively stimulating and overloading the muscle to generate muscle adaptations such as improvements in strength, endurance and power. PRT is an anabolic form of exercise, differing

Progressive resistance training (PRT) or weight lifting training is a common type of strength training for developing the strength and size of skeletal muscles. It uses the force of gravity or in our case compressed air resistance to oppose the force generated by muscle through concentric or eccentric contraction. Effectively stimulating and overloading the muscle to generate muscle adaptations such as improvements in strength, endurance and power. PRT is an anabolic form of exercise, differing substantially from aerobic exercise in its ability to induce muscle hypertrophy and associated metabolic and functional changes. It has been shown in randomised controlled trials (RCTs) of similar cohorts to improve insulin sensitivity, glucose homeostasis, blood pressure, dyslipidaemia, markers of inflammation and catabolism, and visceral obesity, thus addressing virtually all of the known risk factors associated with peripheral arterial disease (PAD). PRT also improves aerobic capacity, osteoarthritis pain and disability, depression, functional status, gait and balance impairments, bone density, and insomnia, thus addressing the spectrum of associated clinical disorders in older adults with PAD. Notably, high intensity PRT is feasible when robust aerobic exercise is impossible (as in our cohort) due to osteoarthritis or advanced peripheral arterial disease. PRT has also been shown to significantly improve walking ability when compared to control and/or baseline values in asymptomatic patients and those with mild to moderate claudication. In addition PRT has also been shown to improve functional status, quality of life and well-being scores in this same cohort. We will be comparing high intensity PRT to low intensity PRT and to a control condition. Participants who receive high intensity resistance training will receive weight lifting exercises of 10 major muscle groups. Frequency of training will be 3 days per week under supervision using pneumatic resistance equipment. The exercises chosen include the large muscle groups of the arms, legs and trunk. More specifically we have chosen exercises that specifically focus on areas where claudication most commonly occurs, such as the calf or thigh. Exercises chosen include: calf plantar flexion, ankle dorsiflexion, knee extension, leg press, leg curl, hip extension, hip abduction, chest press, seated row and lat pulldown. These are symmetrical exercises and functionally relevant to activities of daily living, as well as gait performance, both of which are affected by intermittent claudication. For each exercise participants will perform 3 sets of 8 repetitions, with controlled concentric and eccentric phases (4 seconds per repetition with 2 minutes rest between sets). Exercise to claudication pain was deemed unnecessary due to two recent aerobic exercise trials achieving improvements in walking distances based on a chosen exercise intensity that deliberately did not invoke claudication pain. In addition, in our experience of 25 years of working with persons with PAD, typical high intensity, low volume PRT has never caused the onset of claudication pain. However, if it does occur the participant will be encouraged to continue exercising to complete the set. If the pain becomes unbearable, they will be allowed to stop and rest until the pain dissipates enough for them to complete the set. In addition this group will receive usual medical care advice on foot care, lifestyle change, such as quitting smoking, and maintaining a healthy weight. Advice on completing walking exercise will not be provided. The initial intensity for the high intensity treatment group will be set at 50% of the most recently determined peak strength (1 repetition maximum or 1RM). Intensity will then be increased each session, over a 2 week period until 80% 1RM has been reached. Resistance used will be increased by about 3% per session or as tolerated using Borg scale rating of perceived exertion on a continuous basis throughout the 6 months. Repetition maximum testing will be repeated at 2 week intervals to ascertain progress and regulate intensity. All training will be fully supervised by skilled exercise physiologists to maintain proper intensity and progression, as well as to ensure correct technique. Supervision was deemed necessary for both groups as a recent meta-analysis demonstrated that supervised exercise therapy showed statistically significant and clinically relevant differences in improvements of maximal treadmill walking distance compared with non-supervised exercise regimens. Therefore both training groups will be exercising within a group of up to four participants per one exercise physiologist for approximately one hour, 3 days per week for an overall duration of 6 months. The low intensity training protocol was designed with the intention of mimicking many current community resistance training intensities. Participants who receive low intensity resistance training will be trained by the same exercise physiologists in the same facility under the same training protocol. The one exception will be the change in intensity. The initial intensity for this treatment group will be set at 20% of the most recently determined peak strength (1 repetition maximum or 1RM). Intensity will then be increased each session, over a 1-2 week period, in 3% increments until 30% 1RM has been reached, and the load will be maintained at that level for the duration of the 6-month trial. In addition, as with the high intensity group, this group will receive usual medical care advice on foot care, lifestyle change, such as quitting smoking, and maintaining a healthy weight. Advice on walking exercise will not be provided.

Sponsors

University of Sydney
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Men and women over the age of 50 who suffer from moderate to severe intermittent claudication from PAD as defined by lower extremity ultrasound in Professor Lord’s vascular laboratory will be recruited for this trial. Participants must be sedentary, ambulatory and community dwelling with no contra-indications to progressive resistance training. All participants must be clinically stable for 3 months prior to enrolment in the trial. Clinically stable will be defined as no significant change in claudication symptoms over a 3-month no treatment run-in period, as determined by the 6-minute walk test performed twice at baseline, 3-months apart. We will preferentially recruit elderly (over the age of 70 years) and female participants, as these cohorts have been understudied in the past. Specifically, persons with diabetes, hypertension, coronary artery disease and/or a history of myocardial infarction will not be excluded. Persons who have had previous surgical intervention and/or who are on pharmaceutical treatment for symptoms of PAD will also not be excluded.

Exclusion criteria

Exclusionary criteria include asymptomatic PAD, mild intermittent claudication (>200m initial claudication walking distance), ischaemic rest pain, tissue necrosis or gangrene, significant cognitive impairment, current alcohol or substance abuse, inability to comply with study requirements over the course of 6 months (including baseline and final assessments), those currently undertaking a resistance training or other regular (at least 3 days per week) moderate to high intensity exercise of any kind, and those confined to a nursing home or hostel or who are unable to perform PRT safely under supervision. Persons with specific contraindications to resistance training exercise such as unstable cardiovascular disease, aortic aneurysm, symptomatic hernias, proliferative diabetic retinopathy, retinal laser surgery within 6 weeks, uncontrolled hypertension or rapidly progressive or terminal illness will also be excluded. Persons who are currently actively awaiting surgical intervention for PAD will also be excluded.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026